Quince Therapeutics

IPO

Quince

Public · United States · $285.0M raised

Business Model
B2B
Total Funding
$285.0M
Last Round
$187.0M Corporate RoundJun 2024
Rounds
4
Type
Public

About

Quince Therapeutics is a late-stage biotechnology company developing treatments for rare diseases. Its AIDE technology platform uses an automated process to encapsulate drugs in a patient's own red blood cells, which the company says may improve tolerability, tissue distribution, immunogenicity, and circulation time. Its lead eDSP program applies this approach to dexamethasone sodium phosphate for patients with ataxia-telangiectasia.

Summary

Quince Therapeutics is a Biotech company based in United States. It has raised $285.0M in total across 4 rounds, most recently a $187.0M Corporate Round round in Jun 2024. Investors include Sequoia Capital, Sofinnova Partners and Pfizer Ventures.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Corporate RoundCorporate RoundJun 2024
$22.0M

Sign up to see all 5 rounds

Corporate Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Quince Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/quince-therapeutics"><img src="https://indexed.vc/api/badge/company/quince-therapeutics" alt="Quince Therapeutics on Indexed.vc" width="260" height="76" /></a>